| Product Code: ETC11380398 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of anti-rheumatics in Ireland saw significant growth in 2024, with Germany, UK, USA, Canada, and other areas being the top exporting countries. The market concentration, as measured by the HHI, increased from moderate to high in 2024, indicating a more consolidated market. The impressive Compound Annual Growth Rate (CAGR) of 23.25% from 2020 to 2024 reflects the strong demand for anti-rheumatics in Ireland. Moreover, the remarkable growth rate of 68.68% from 2023 to 2024 suggests a rapid expansion in the market during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Anti Rheumatics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Anti Rheumatics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Anti Rheumatics Market - Industry Life Cycle |
3.4 Ireland Anti Rheumatics Market - Porter's Five Forces |
3.5 Ireland Anti Rheumatics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Anti Rheumatics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Ireland Anti Rheumatics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Anti Rheumatics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Anti Rheumatics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population leading to a higher prevalence of rheumatic diseases |
4.2.2 Increasing awareness about the importance of early detection and treatment of rheumatic conditions |
4.2.3 Technological advancements in the development of new anti-rheumatic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of anti-rheumatic drugs |
4.3.2 High cost associated with anti-rheumatic treatments leading to affordability issues for some patients |
5 Ireland Anti Rheumatics Market Trends |
6 Ireland Anti Rheumatics Market, By Types |
6.1 Ireland Anti Rheumatics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Anti Rheumatics Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland Anti Rheumatics Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Ireland Anti Rheumatics Market Revenues & Volume, By DMARDs, 2021 - 2031F |
6.1.5 Ireland Anti Rheumatics Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.2 Ireland Anti Rheumatics Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Ireland Anti Rheumatics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Ireland Anti Rheumatics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Ireland Anti Rheumatics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Anti Rheumatics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ireland Anti Rheumatics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Ireland Anti Rheumatics Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Ireland Anti Rheumatics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Anti Rheumatics Market Revenues & Volume, By Retail, 2021 - 2031F |
6.4.3 Ireland Anti Rheumatics Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.4.4 Ireland Anti Rheumatics Market Revenues & Volume, By Online, 2021 - 2031F |
7 Ireland Anti Rheumatics Market Import-Export Trade Statistics |
7.1 Ireland Anti Rheumatics Market Export to Major Countries |
7.2 Ireland Anti Rheumatics Market Imports from Major Countries |
8 Ireland Anti Rheumatics Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation |
8.2 Patient adherence rate to prescribed anti-rheumatic medications |
8.3 Number of clinical trials for innovative anti-rheumatic drugs |
8.4 Rate of adoption of new anti-rheumatic treatments |
8.5 Percentage of patients achieving remission or disease control with anti-rheumatic therapy |
9 Ireland Anti Rheumatics Market - Opportunity Assessment |
9.1 Ireland Anti Rheumatics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Anti Rheumatics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Ireland Anti Rheumatics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Anti Rheumatics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Anti Rheumatics Market - Competitive Landscape |
10.1 Ireland Anti Rheumatics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Anti Rheumatics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |